Peter Attia
FollowThe latest interviews, podcast appearances, and blog posts from Peter Attia, updated daily.
Lung cancer screening in never-smokers: the data
Although not endorsed by by guidelines, evidence supports it as a rational…
#397 ‒ Endometriosis and adenomyosis: diagnosis, fertility, reproductive aging, and emerging treatments | Renato Tomioka, M.D., Ph.D.
“If we diagnose an adolescent—or even young women—earlier, we can avoid 40% of the lesions or the disease burden.” —Renato…
Can AI models reason like clinicians?
A study evaluating frontier LLMs across the clinical workflow reveals a critical gap in the kind of reasoning that matters most for patient safety.
#396 ‒ Breast cancer screening: understanding risk, deciding when to start and how often to screen, and choosing the right imaging strategy
“The science here is not the bottleneck. The tools exist. The evidence is strong.
Beyond the mammogram: a framework for smarter breast cancer screening
A risk-based framework for deciding when, how often, and which way to…
#395 – Brain lipidology: understanding APOE, cholesterol homeostasis, Alzheimer’s disease risk, and the effects of lipid-lowering therapies on brain health | Tom Dayspring, M.D.
"Unfortunately, a prevalent belief out there in the real world is ‘I don't ever want to lower LDL cholesterol too much, because I'll deprive the brain and I'll injure the brain’ . .
The beginning of the end of atherosclerosis?
Optimized programs with heavy weights are the gold standard for trained athletes. How much do they matter when starting fresh?
#394 ‒ Sleep pharmacology: the role of medications in healthy sleep, the promise of emerging therapies, and the evidence for common sleep supplements
“Different drugs vary in how quickly they work, how long they last, and which sleep problems they target.
Resistance training: lowering the barrier to entry
Optimized programs with heavy weights are the gold standard for trained athletes. How much do they matter when starting fresh?